Literature DB >> 9461056

Predicting the in vitro toxicity of synthetic beta-amyloid (1-40).

S K Brining1.   

Abstract

The in vitro toxicity of synthetic beta-amyloid (betaA4) is variable and unpredictable, limiting its use as a research tool. This study describes a method using Congo red (CR) to predict the in vitro toxicity of betaA4 solutions. Histopathologically, CR is used to stain the neuritic, betaA4-containing plaques, one of the hallmarks of Alzheimer's disease. In this study, synthetic betaA4 solutions were incubated with CR at a molar ratio of 1.0:2.5. The solutions were centrifuged and the absorbance of the supernatants were measured. Predictions of nontoxicity correlated with absorbance readings near zero. Toxicity was evaluated relative to control cells (vehicle only), using a hemocytometer to count PC-12 cells that excluded trypan blue. The positive predictive value of the test was 78% and the negative predictive value was 100%. To use this test, the toxic concentration(s) of betaA4 must first be established empirically. Then, the CR test can be used to evaluate the potential toxicity of betaA4 solutions at similar concentrations. Thus, this test can be used under a variety of laboratory circumstances.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9461056     DOI: 10.1016/s0197-4580(97)00153-x

Source DB:  PubMed          Journal:  Neurobiol Aging        ISSN: 0197-4580            Impact factor:   4.673


  5 in total

1.  Single-particle characterization of Aβ oligomers in solution.

Authors:  Erik C Yusko; Panchika Prangkio; David Sept; Ryan C Rollings; Jiali Li; Michael Mayer
Journal:  ACS Nano       Date:  2012-06-21       Impact factor: 15.881

2.  Beta-amyloid activates the mitogen-activated protein kinase cascade via hippocampal alpha7 nicotinic acetylcholine receptors: In vitro and in vivo mechanisms related to Alzheimer's disease.

Authors:  K T Dineley; M Westerman; D Bui; K Bell; K H Ashe; J D Sweatt
Journal:  J Neurosci       Date:  2001-06-15       Impact factor: 6.167

3.  Aggregated beta amyloid peptide 1-40 decreases Ca2+- and cholinergic receptor-mediated phosphoinositide degradation by alteration of membrane and cytosolic phospholipase C in brain cortex.

Authors:  A Zambrzycka; R P Strosznajder; J B Strosznajder
Journal:  Neurochem Res       Date:  2000-02       Impact factor: 3.996

4.  Bisphosphonate enhances TRAIL sensitivity to human osteosarcoma cells via death receptor 5 upregulation.

Authors:  Myung Hee Moon; Jae Kyo Jeong; Jae Suk Seo; Jae Won Seol; You Jin Lee; Meilang Xue; Christopher J Jackson; Sang-Youel Park
Journal:  Exp Mol Med       Date:  2011-03-31       Impact factor: 8.718

Review 5.  Abeta aggregation and possible implications in Alzheimer's disease pathogenesis.

Authors:  Prashant R Bharadwaj; Ashok K Dubey; Colin L Masters; Ralph N Martins; Ian G Macreadie
Journal:  J Cell Mol Med       Date:  2009-03       Impact factor: 5.310

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.